Medtronic Cash on Hand 2010-2024 | MDT
Medtronic cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Medtronic cash on hand for the quarter ending January 31, 2024 was $8.321B, a 25.29% decline year-over-year.
- Medtronic cash on hand for 2023 was $7.959B, a 24.72% decline from 2022.
- Medtronic cash on hand for 2022 was $10.573B, a 2.26% decline from 2021.
- Medtronic cash on hand for 2021 was $10.817B, a 1.2% decline from 2020.
| Medtronic Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $7,959 |
| 2022 | $10,573 |
| 2021 | $10,817 |
| 2020 | $10,948 |
| 2019 | $9,848 |
| 2018 | $11,227 |
| 2017 | $13,708 |
| 2016 | $12,634 |
| 2015 | $19,480 |
| 2014 | $14,241 |
| 2013 | $11,130 |
| 2012 | $9,350 |
| 2011 | $2,428 |
| 2010 | $3,775 |
| 2009 | $1,676 |
| Medtronic Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-01-31 | $8,321 |
| 2023-10-31 | $7,734 |
| 2023-07-31 | $7,876 |
| 2023-04-30 | $7,959 |
| 2023-01-31 | $11,137 |
| 2022-10-31 | $11,430 |
| 2022-07-31 | $8,873 |
| 2022-04-30 | $10,573 |
| 2022-01-31 | $11,221 |
| 2021-10-31 | $10,669 |
| 2021-07-31 | $10,595 |
| 2021-04-30 | $10,817 |
| 2021-01-31 | $14,639 |
| 2020-10-31 | $14,277 |
| 2020-07-31 | $13,012 |
| 2020-04-30 | $10,948 |
| 2020-01-31 | $11,628 |
| 2019-10-31 | $10,398 |
| 2019-07-31 | $10,683 |
| 2019-04-30 | $9,848 |
| 2019-01-31 | $9,142 |
| 2018-10-31 | $10,133 |
| 2018-07-31 | $11,004 |
| 2018-04-30 | $11,227 |
| 2018-01-31 | $14,436 |
| 2017-10-31 | $13,526 |
| 2017-07-31 | $13,088 |
| 2017-04-30 | $13,708 |
| 2017-01-31 | $11,458 |
| 2016-10-31 | $11,257 |
| 2016-07-31 | $12,810 |
| 2016-04-30 | $12,634 |
| 2016-01-31 | $17,286 |
| 2015-10-31 | $17,229 |
| 2015-07-31 | $17,982 |
| 2015-04-30 | $19,480 |
| 2015-01-31 | $31,148 |
| 2014-10-31 | $14,464 |
| 2014-07-31 | $13,962 |
| 2014-04-30 | $14,241 |
| 2014-01-31 | $13,667 |
| 2013-10-31 | $12,584 |
| 2013-07-31 | $11,404 |
| 2013-04-30 | $11,130 |
| 2013-01-31 | $2,464 |
| 2012-10-31 | $2,675 |
| 2012-07-31 | $2,491 |
| 2012-04-30 | $9,350 |
| 2012-01-31 | $2,345 |
| 2011-10-31 | $2,166 |
| 2011-07-31 | $2,521 |
| 2011-04-30 | $2,428 |
| 2011-01-31 | $3,467 |
| 2010-10-31 | $3,544 |
| 2010-07-31 | $3,917 |
| 2010-04-30 | $3,775 |
| 2010-01-31 | $2,292 |
| 2009-10-31 | $1,542 |
| 2009-07-31 | $1,544 |
| 2009-04-30 | $1,676 |
| 2009-01-31 | $1,743 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $112.493B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.948B | 23.83 |
| Stryker (SYK) | United States | $126.472B | 30.29 |
| Boston Scientific (BSX) | United States | $109.225B | 34.79 |
| EssilorLuxottica (ESLOY) | France | $102.697B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.401B | 28.03 |
| ResMed (RMD) | United States | $32.412B | 30.43 |
| Terumo (TRUMY) | Japan | $26.228B | 37.04 |
| Koninklijke Philips (PHG) | Netherlands | $25.491B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.889B | 15.90 |
| Baxter (BAX) | United States | $18.054B | 12.84 |
| Insulet (PODD) | United States | $12.646B | 56.08 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.240B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.583B | 28.08 |
| BellRing Brands (BRBR) | United States | $7.715B | 36.13 |
| Lantheus Holdings (LNTH) | United States | $5.517B | 13.75 |
| Haemonetics (HAE) | United States | $4.900B | 24.24 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.120B | 12.49 |
| Prestige Consumer Healthcare (PBH) | United States | $3.300B | 15.79 |
| Envista Holdings (NVST) | United States | $3.241B | 13.38 |
| QuidelOrtho (QDEL) | United States | $3.011B | 16.71 |
| Neogen (NEOG) | United States | $2.881B | 27.71 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.816B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.741B | 54.29 |
| TG Therapeutics (TGTX) | United States | $2.739B | 77.04 |
| ICU Medical (ICUI) | United States | $2.546B | 22.47 |
| Agios Pharmaceuticals (AGIO) | United States | $1.997B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.752B | 51.36 |
| InMode (INMD) | Israel | $1.583B | 8.42 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| Owens & Minor (OMI) | United States | $1.546B | 13.47 |
| AdaptHealth (AHCO) | United States | $1.308B | 9.74 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| BioLife Solutions (BLFS) | United States | $1.058B | 0.00 |
| AtriCure (ATRC) | United States | $1.053B | 0.00 |
| Canopy Growth (CGC) | Canada | $1.004B | 0.00 |
| Evolus (EOLS) | United States | $0.829B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.739B | 15.73 |
| Cresco Labs (CRLBF) | United States | $0.722B | 0.00 |
| Quanterix (QTRX) | United States | $0.684B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.639B | 15.02 |
| Valneva SE (VALN) | France | $0.616B | 0.00 |
| PetIQ (PETQ) | United States | $0.577B | 18.86 |
| Jin Medical (ZJYL) | China | $0.527B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.479B | 29.96 |
| ZimVie (ZIMV) | United States | $0.455B | 38.79 |
| Biote (BTMD) | United States | $0.435B | 8.33 |
| OraSure Technologies (OSUR) | United States | $0.398B | 12.82 |
| Aurora Cannabis (ACB) | Canada | $0.388B | 0.00 |
| Cerus (CERS) | United States | $0.375B | 0.00 |
| Zynex (ZYXI) | United States | $0.350B | 47.87 |
| MacroGenics (MGNX) | United States | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.294B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 26.61 |
| TriSalus Life Sciences (TLSI) | United States | $0.251B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.244B | 15.39 |
| Omeros (OMER) | United States | $0.242B | 0.00 |
| Veru (VERU) | United States | $0.215B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.204B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.169B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.156B | 75.00 |
| InterCure (INCR) | Israel | $0.149B | 25.23 |
| Jushi Holdings (JUSHF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 19.32 |
| Cellectar Biosciences (CLRB) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.103B | 8.84 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| MariMed (MRMD) | United States | $0.095B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.092B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| Rockwell Medical (RMTI) | United States | $0.052B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.046B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.37 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |